Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 2665

BillFederalSenateIn Committee
A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety.
About This Bill
Committee
Latest Action · April 12, 2018
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced
April 12, 2018
Cosponsors (1)
1D 0R
View PDF ↗
SummaryFull TextCommentsAnnotations

Full Text

The official full text of this bill isn’t available inside AllCiv yet. Read it on Congress.gov:

A plain-language summary is on the Summary tab — you can highlight and annotate it there.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.